Asta, through its third-party managing agency at Lloyd’s, announced the “in-principle” approval of a syndicate-in-a-box (SIAB) to deliver a breakthrough insurance product that aims to accelerate the development of new therapeutic drugs. MCI Syndicate 1966, supplemented by Lloyd’s consortia, is …
European authorities are investigating whether popular weight-loss and diabetes drugs including Novo Nordisk A/S’s Wegovy may be linked to complications during anesthesia. The European Medicines Agency’s safety committee, PRAC, is discussing the potential safety issue during its meeting this week. …
Moderna’s suit against Pfizer and partner BioNtech over alleged COVID-vaccine-related patent infringement – and the targets’ countersuit – might suggest an abrupt return to business as usual after an unprecedented period of cooperation among life sciences companies during the height …
The European Union’s drug regulator expanded its investigation into a possible risk of suicidal thoughts associated with a new class of weight-loss medicines and a separate analysis found that most patients stopped taking the medications after a year. The European …
The European Medicines Agency (EMA) is probing Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland’s health regulator flagged three cases of patients on the drugs thinking about suicide or self-harm. Shares of the Danish drugmaker fell about …
The New York-based biotech and life sciences company Enzo Biochem reported it was hit by a ransomware attack on April 6. The company has since reported that clinical test information of approximately 2,470,000 individuals was accessed and possibly acquired in …
A European Medicines Agency (EMA) committee said on Friday it has started a review of decongestant medicines for cold and flu that contain the ingredient pseudoephedrine following safety concerns. The EMA said the review was due to reports of conditions …
PARIS – A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family whose child suffered from a form of autism caused by its epilepsy drug Valproate, saying the drugmaker failed to inform …
A French court ruled that families of children who suffered side effects from the epilepsy medicine Depakine can join in a class-action lawsuit against drugmaker Sanofi. The company should have warned of the risk of birth defects for pregnant women …
Specialist insurer Beazley has launched a suite of covers to protect organizations within Asia Pacific’s rapidly expanding life sciences sector. In an environment in which risk exposures are complex and varied – from the release of unsafe medical devices and …
